GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Markets

Ligand Pharmaceuticals rises 2.73% in Wednesday's session

Published by Global Banking & Finance Review

Posted on October 21, 2026

1 min read
Add as preferred source on Google
LGND 314.78 +2.73% last traded price, 21 Oct 2026
Previous close
306.40
Market cap
—

Source: Eulerpool. The figures in this article were checked against this snapshot before publication.

Ligand Pharmaceuticals in the United States health care sector saw its shares last traded 2.73% higher than the previous close, at 314.78 USD on 21 October 2026. The previous close was 306.40 USD.

Last traded price314.78 USD
Previous close306.40 USD
Change from the previous close+2.73%

Prices of Ligand Pharmaceuticals (LGND), listed in United States, in the currency the stock trades in. The last traded price is the last price the shares changed hands at in the session of 21 October 2026, as reported after the market closed. It is not the exchange's official closing price, and the two can differ. The change compares it with the official close of the previous session, 20 October 2026. We report a stock the day it ends a session 2% or more away from its previous close, where at least 100,000 shares traded in the previous session. Source: Eulerpool. How we compile these reports.

Ligand Pharmaceuticals — daily LGND Delayed

Related Articles

More from Markets

Explore more articles in the Markets category